Avelar Rui (CIK 1432063) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-20). Recent activity: Sell EOLS (3,119 shares), Buy EOLS (8,804 shares), Sell EOLS (29,996 shares), Buy EOLS (94,913 shares), Sell EOLS (2,261 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-20 | Evolus, Inc. (EOLS) | See Remarks | Sell | 3,119 | $14,815 |
| 2026-03-18 | Evolus, Inc. (EOLS) | Chief Medical Officer and Head of Research & Development | Buy | 8,804 | $0 |
| 2026-03-18 | Evolus, Inc. (EOLS) | Chief Medical Officer and Head of Research & Development | Sell | 29,996 | $146,680 |
| 2026-02-19 | Evolus, Inc. (EOLS) | Chief Medical Officer and Head of R&D | Buy | 94,913 | $0 |
| 2025-12-29 | Evolus, Inc. (EOLS) | Chief Medical Officer & Head of Research and Development | Sell | 2,261 | $16,166 |
| 2025-05-14 | Evolus, Inc. (EOLS) | Chief Medical Officer & Head of Research and Development | Sell | 3,385 | $33,410 |
来源：SEC Form 4 申报文件 · 截至 2026-03-20